palmitoylcarnitine has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Bakheit, A; Melchini, A; Mithen, R; Saha, S; Traka, M | 1 |
1 other study(ies) available for palmitoylcarnitine and Prostatic Neoplasms
| Article | Year |
|---|---|
Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer.
Topics: Calcium; Cell Survival; Cells, Cultured; Chromatography, Liquid; Humans; Inflammation Mediators; Male; Mass Spectrometry; Palmitoylcarnitine; Prostate; Prostatic Neoplasms; Signal Transduction | 2016 |